Beijing Science Sun Pharmaceutical (300485.SZ) Earnings Analysis

Beijing Science Sun Pharmaceutical (300485.SZ) has no confirmed upcoming earnings date. Trailing P/E -214.39.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 300485.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 300485.SZ. This page updates as the calendar is published.

300485.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-09-290.00846 CNYn/an/an/a
2025-06-300.01623 CNYn/an/an/a
2025-04-300.06092 CNYn/an/an/a
2025-03-310.083 CNYn/an/an/a
2024-09-290.01443 CNYn/an/an/a

300485.SZ valuation and analyst view

Trailing P/E-214.39
Trailing EPS-0.04305 CNY
Price / book1.28
Dividend yield0.34%
Market cap4.33B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Beijing Science Sun Pharmaceutical (300485.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 300485.SZ. This page updates as the calendar is published.

Did 300485.SZ beat earnings last quarter?

Consensus estimate data was not available for 300485.SZ's 2025-09-29 report.

What is 300485.SZ's current P/E ratio and EPS?

300485.SZ trades at a trailing P/E of -214.39 on trailing EPS of -0.04305002175779751 CNY.

What do analysts rate 300485.SZ?

300485.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.